In this study, we describe homozygous loss-of-function CARMIL2 mutations in four human patients from two different families presenting with the highly unusual phenotype of disseminated EBV+ smooth muscle tumours (SMT). The gene discussed is CARMIL2; the disease is smooth muscle tumor.